SCHEMBL29851330

SCHEMBL29851330

COc1cc(NC2CCN(C3C4CC5CC(C4)CC3C5)CC2)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ DRD4 P21917 1/20 0.39
▸ CXCR3 P49682 1/20 0.39
▸ CCR6 P51684 2/20 0.36
▸ GFER P55789 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ USP2 O75604 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23479987 1.00 SIGMAR1 (0.42) SIGMAR1ALDH1A1SMN1; SMN2DRD4CXCR3
SCHEMBL23480485 0.88 HSD11B1 (0.38) SIGMAR1ALDH1A1DRD4CCR6GFER
SCHEMBL29171007 0.88 HSD11B1 (0.38) SIGMAR1ALDH1A1DRD4CCR6GFER
SCHEMBL23480099 0.88 HSD11B1 (0.38) SIGMAR1ALDH1A1DRD4CCR6GFER
SCHEMBL24658852 0.84 ALDH1A1 (0.34) SIGMAR1ALDH1A1SMN1; SMN2CCR6GFER
SCHEMBL29851363 0.81 CYP3A4 (0.43) SIGMAR1ALDH1A1SMN1; SMN2DRD4CXCR3
SCHEMBL23480093 0.81 CYP3A4 (0.43) SIGMAR1ALDH1A1SMN1; SMN2DRD4CXCR3
SCHEMBL12749148 0.80 POLB (0.51) ALDH1A1POLBCYP3A4TSHRHSD17B10
SCHEMBL29973250 0.80 POLB (0.51) ALDH1A1POLBCYP3A4TSHRHSD17B10
SCHEMBL24659060 0.80 HTR4 (0.32) SIGMAR1ALDH1A1SMN1; SMN2GFERPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929675-B Adamantane derivatives as focal adhesion kinase inhibitors 三进制药株式会社 2024-02-13 — — CN disclosed
CN-114929675-A Novel adamantane derivatives as inhibitors of focal adhesion kinase 三进制药株式会社 2022-08-19 — — CN disclosed
Send feedback